Clinical trial condition

NSCLC

Explore clinical trials studying NSCLC. Study availability and eligibility vary by location and protocol.

357 public trials 121 recruiting studies

Refine in advanced search Browse all conditions

NSCLC trial results

Completed

A Trial of PTS Via Intratumoral Injection in Patients With Central Air Way NSCLC Severe Obstruction

NCT03448146

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: The First Affiliated Hospital of Guangzhou Medical University Guangzhou, China

View Trial Details

Completed

PET Response During Chemoradiation of Lung Cancer

NCT02315053

Conditions: NSCLC
Locations: The Netherlands Cancer Institute Amsterdam, North Holland, Netherlands

View Trial Details

Completed

Pilot Study of Safety and Tolerability of Nutrifriend Cachexia in NSCLC Cachexia

NCT02515032

Conditions: Body Weight, Body Weight Changes, Cachexia, +5 more
Locations: GH Varaždin Varaždin, Croatia

GH Zadar Zadar, Croatia

CHC Sestre Milosrdnice Zagreb, Croatia

CHC Zagreb, Zagreb, Croatia

View all 14 locations

View Trial Details

Completed

LUMINIST: LUng Cancer Molecular Insights Non Interventional Study

NCT02300831

Conditions: Lung Diseases, Lung Neoplasms, NSCLC, +5 more
Locations: Research Site Camperdown, Australia

Research Site Darlinghurst, Australia

Research Site Kurralta Park, Australia

Research Site Wendouree, Australia

View all 85 locations

View Trial Details

Completed

Efficacy/Safety of Imprime PGG With Cetuximab & Paclitaxel/Carboplatin Therapy in Pts With Untreated Advanced Non-Small Cell Lung Cancer

NCT00874848

Conditions: NSCLC
Locations: Medical College of Georgia Augusta, Georgia, United States

Providence Medical Group Terre Haute, Indiana, United States

University of Minnesota Minneapolis, Minnesota, United States

Mary Crowley Medical Research Center Dallas, Texas, United States

View all 14 locations

View Trial Details

Completed

Predictive Value of FDG-TEP During Radiotherapy or Chemo-radiotherapy in Patients With NCSC on the One-year Survival

NCT01261598

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Centre Henri Becquerel Rouen, France

View Trial Details

Completed

Phase II of Zactima Maintenance for Locally Advanced or Metastatic Non-small-cell Lung Carcinoma (NSCLC) Following Platinum-doublet Chemotherapy

NCT00777179

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Research Site Cheongju-si, Republic of Korea, South Korea

Research Site Gyeonggi-do, Republic of Korea, South Korea

Research Site Gyeongsangnam-Do, Republic of Korea, South Korea

Research Site Incheon, Republic of Korea, South Korea

View Trial Details

Completed

Oral Chemotherapy And Platinum With Radiotherapy Followed Or Not By Consolidation With The Same Chemotherapy In Locally Advanced Non Small Cell Lung Cancer

NCT00683514

Conditions: NSCLC
Locations: Pierre Fabre Pharma GmbH Freiburg im Breisgau, Jechtinger Str. 13, Germany

View Trial Details

Completed

Iressa v BSC (Best Supportive Care) in First Line NSCLC

NCT00259064

Conditions: NSCLC
Locations: Research Site Bedford Park, Australia

Research Site Chermside, Australia

Research Site Concord, Australia

Research Site Melbourne, Australia

View all 36 locations

View Trial Details

Completed

Clinical Value of Sequential Gefitinib With Pemetrexed/Platinum for Advanced NSCLC

NCT01769066

Conditions: NSCLC
Locations: Cancer hospital Fudan University Shanghai, Shanghai Municipality, China

View Trial Details

NSCLC

NSCLC trial results

Related conditions